With 0.8 million shares changed hands, the volume of the stock remained lighter than its average volume of 5.65 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $0.1299 whereas the lowest price it dropped to was $0.124. The 52-week range on NLSP shows that it touched its highest point at $1.01 and its lowest point at $0.11 during that stretch. It currently has a 1-year price target of $4.00. Beta for the stock currently stands at -0.57.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NLSP was down-trending over the past week, with a drop of -8.69%, but this was down by -27.75% over a month. Three-month performance dropped to -47.92% while six-month performance fell -24.29%. The stock lost -84.03% in the past year, while it has lost -78.81% so far this year. A look at the trailing 12-month EPS for NLSP yields -0.34 with Next year EPS estimates of -0.04.
Float and Shares Shorts:
At present, 32.43 million NLSP shares are outstanding with a float of 29.84 million shares on hand for trading. On 2024-09-13, short shares totaled 1.25 million, which was 267.00001000000003 higher than short shares on 1723680000. In addition to Mr. Alexander Zwyer M.B.A. as the firm’s CEO & Director, Dr. Eric Konofal M.D., Ph.D. serves as its Co-Founder & Chief Scientific Officer.
Institutional Ownership:
Through their ownership of 0.25869 of NLSP’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NLSP since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
